# US 2026/0043720 A1 · STABILIZED TWO-PART HEMATOXYLIN SOLUTION UTILIZING pH ADJUSTMENT

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0043720 A1
- Document ID: US20260043720A1
- Status: Published application
- Kind: A1
- Application number: 19/362,890
- Filed: 2025-10-20
- Published: 2026-02-12
- Earliest claimed: 2017-05-10
- Assignees: Ventana Medical Systems, Inc.
- Applicants: Ventana Medical Systems, Inc.
- Inventors: Edward E. Durrant; Christopher A. Koerber
- Web page: https://patentgrep.com/patent/US20260043720A1

## CPC

- G01N 1/30: Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis}
- C09B 65/00: Compositions containing mordants
- C09B 67/0014: {Influencing the physical properties by treatment with a liquid, e.g. solvents}
- C09B 67/0017: {Influencing the physical properties by treatment with an acid, H2SO4}
- C01D 1/00: Oxides or hydroxides of sodium, potassium or alkali metals in general
- G01N 2001/302: {Stain compositions}
- Y10S 436/826: Additives, e.g. buffers, diluents, preservatives
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- C01D: COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM (metal hydrides {monoborane, diborane or addition complexes thereof} C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts of peroxyacids C01B15/00; sulfides C01B17/22; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; {compounds other than ammonia and cyanogen, containing nitrogen and other non-metals C01B21/082}; metal amides C01B21/092; nitrites C01B21/50; phosphides C01B21/50; {compounds of noble gases C01B23/0005}; phosphides C01B25/08; salts of oxyacids of phosphorus C01B25/16; carbides C01B32/90; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; cyanides C01C3/08; salts of cyanic acid C01C3/14; salts of cyanamide C01C3/16; thiocyanates C01C3/20)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present disclosure provides stabilized hematoxylin formulations having a pH of less than 2.4. The present disclosure also provides methods of using such stabilized hematoxylin formulations to stain biological samples.

## Claims

### Claim 1

A kit comprising a first component and a second component,
the first component comprising a stabilized hematoxylin formulation comprising a hematoxylin dye and an acid in an amount ranging from about 0.1% to about 10% by total volume of the stabilized hematoxylin formulation, and wherein the stabilized hematoxylin formulation has a pH of less than 2.4; and
the second component comprising a strong base or a buffer.

### Claim 2 (depends on 1)

The kit of claim 1, wherein the second component provided in an amount relative to the first component such that when the first and second components are mixed, the pH of the hematoxylin solution increases to between about 2.4 to about 2.6.

### Claim 3 (depends on 1)

The kit of claim 1, wherein the second component is provided in an amount relative to the first component such that when the first and second components are mixed, the pH of the hematoxylin solution increases to greater than 2.5.

### Claim 4 (depends on 1)

The kit of claim 1, wherein the second component is provided in an amount relative to the first component such that when the first and second components are mixed, the pH of the hematoxylin solution ranges from between about 2.45 to about 2.54.

### Claim 5 (depends on 1)

The kit of claim 1, wherein the second component is provided in an amount relative to the first component such that when the first and second components are mixed, the pH of the hematoxylin solution ranges from between about 2.5 to about 2.6.

### Claim 6 (depends on 1)

The kit of claim 1, wherein the first component further comprises a mordant, and an oxidant.

### Claim 7 (depends on 1)

The kit of claim 1, wherein the first component further comprises a shelf-life extending agent.

### Claim 8 (depends on 7)

The kit of claim 7, wherein the shelf-life extending agent is a polyol.

### Claim 9 (depends on 8)

The kit of claim 8, wherein the polyol is selected from the group consisting of propylene glycol, ethylene glycol, and mixtures thereof.

### Claim 10 (depends on 1)

The kit of claim 1, wherein the stabilized hematoxylin formulation consists essentially of hematoxylin dye, a mordant, an oxidant, and the acid.

### Claim 11 (depends on 1)

The kit of claim 1, wherein the strong base is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide, and ammonia.

### Claim 12 (depends on 1)

The kit of claim 1, wherein the buffer is selected from the group consisting of a cyanoacetate, fumarate, and sulfate.

### Claim 13 (depends on 1)

The kit of claim 1, further comprising a third component, the third component comprising a counterstain.

### Claim 14 (depends on 13)

The kit of claim 13, wherein the counterstain selected from the group consisting of eosin Y, orange G, light green SF yellowish, Bismark Brown, and fast green FCF.

### Claim 15

A system comprising:
an processing system, wherein the processing system includes:
a first container comprising a stabilized hematoxylin formulation comprising hematoxylin dye and an acid in an amount ranging from about 0.1% to about 10% by total volume of the stabilized hematoxylin formulation, and wherein the stabilized hematoxylin formulation has a pH of less than 2.4;
a second container comprising a readjustment solution, wherein the first and second containers are in fluidic communication with a mixing receptacle such that the stabilized hematoxylin formulation and the readjustment solution can be combined to provide a hematoxylin staining solution.

### Claim 16 (depends on 15)

The system of claim 15, further comprising a substrate holder for holding the biological sample mounted on the substrate, the substrate holder being in fluidic communication with the mixing receptacle.

### Claim 17 (depends on 15)

The system of claim 15, wherein the readjustment solution comprises a strong base or a buffer.

### Claim 18 (depends on 17)

The method of claim 17, wherein the strong base is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide, and ammonia.

### Claim 19 (depends on 17)

The method of claim 17, wherein the buffer has a pKa ranging from about 1.5 to about 3.5.

### Claim 20 (depends on 17)

The method of claim 17, wherein the readjustment solution further comprises an additive selected from the group consisting of a shelf-life extending agent, an oxidant, and a mordant.
